Drug discovery and development for neglected diseases: the DNDi model

by Eric Chatelain, Jean-Robert Ioset
Published 2011-03-01

Film-Forming Systems for the Delivery of DNDI-0690 to Treat Cutaneous Leishmaniasis

by Katrien Van Bocxlaer, Kerri-Nicola McArthur, Andy Harris, Mo Alavijeh, Stéphanie Braillard, Charles E. Mowbray, Simon L. Croft
Published 2021-04-01

International cooperation and non-profit organizations: re-reading the institutional role in combating neglected diseases

by Marcos Vinício Chein Feres, Pedro Henrique Oliveira Cuco, Lorena Abbas da Silva
Published 2015-12-01

O Programa de VHC da DNDi e o sistema de propriedade intelectual: uma abordagem de saúde pública para a epidemia de Hepatite C

by Marcos Vinício Chein Feres, Leonardo da Silva Sant Anna, Alan Rossi Silva
Published 2020-09-01

Sequential Self-Repetitive Reaction Toward Full Polyimides Featuring Hyperbranched Structures With Stable Optical Nonlinearity.

by Yan-Ling Huang, 黃嬿玲
Published 2012

Novel benzoxaborole, nitroimidazole and aminopyrazoles with activity against experimental cutaneous leishmaniasis

by Katrien Van Bocxlaer, Diana Caridha, Chad Black, Brian Vesely, Susan Leed, Richard J. Sciotti, Gert-Jan Wijnant, Vanessa Yardley, Stéphanie Braillard, Charles E. Mowbray, Jean-Robert Ioset, Simon L. Croft
Published 2019-12-01

The drug and vaccine landscape for neglected diseases (2000–11): a systematic assessment

by Dr. Belen Pedrique, MD, Nathalie Strub-Wourgaft, MD, Claudette Some, PharmD, Piero Olliaro, MD, Patrice Trouiller, PharmD, Nathan Ford, PhD, Bernard Pécoul, MD, Jean-Hervé Bradol, MD
Published 2013-12-01

Mandatory Notification of Chronic Chagas Disease: Confronting the Epidemiological Silence in the State of Goiás, Brazil

by Liliane da Rocha Siriano, Andrea Marchiol, Marina Pereira Certo, Juan-Carlos Cubides, Colin Forsyth, Fabrício Augusto de Sousa
Published 2020-06-01

In vitro and in vivo pharmacodynamics of three novel antileishmanial lead series

by M. Van den Kerkhof, D. Mabille, E. Chatelain, C.E. Mowbray, S. Braillard, S. Hendrickx, L. Maes, G. Caljon
Published 2018-04-01

Identification of Resistance Determinants for a Promising Antileishmanial Oxaborole Series

by Magali Van den Kerkhof, Philippe Leprohon, Dorien Mabille, Sarah Hendrickx, Lindsay B. Tulloch, Richard J. Wall, Susan Wyllie, Eric Chatelain, Charles E. Mowbray, Stéphanie Braillard, Marc Ouellette, Louis Maes, Guy Caljon
Published 2021-06-01

Development of emodepside as a possible adulticidal treatment for human onchocerciasis-The fruit of a successful industrial-academic collaboration.

by Jürgen Krücken, Lindy Holden-Dye, Jennifer Keiser, Roger K Prichard, Simon Townson, Benjamin L Makepeace, Marc P Hübner, Steffen R Hahnel, Ivan Scandale, Achim Harder, Daniel Kulke
Published 2021-07-01

Route map for the discovery and pre-clinical development of new drugs and treatments for cutaneous leishmaniasis

by Diana Caridha, Brian Vesely, Katrien van Bocxlaer, Byron Arana, Charles E. Mowbray, Sima Rafati, Silvia Uliana, Rosa Reguera, Mara Kreishman-Deitrick, Richard Sciotti, Pierre Buffet, Simon L. Croft
Published 2019-12-01

Mycetoma and Neglected Tropical Diseases

by Matt Dias
Published 2016-05-01

New Drugs for Human African Trypanosomiasis: A Twenty First Century Success Story

by Emily A. Dickie, Federica Giordani, Matthew K. Gould, Pascal Mäser, Christian Burri, Jeremy C. Mottram, Srinivasa P. S. Rao, Michael P. Barrett
Published 2020-02-01

In Vitro Susceptibility to Miltefosine of <i>Leishmania infantum</i> (syn. <i>L.</i> <i>chagasi</i>) Isolates from Different Geographical Areas in Brazil

by Caroline Ricce Espada, Erica V. de Castro Levatti, Mariana Côrtes Boité, Dorcas Lamounier, Jorge Alvar, Elisa Cupolillo, Carlos Henrique Nery Costa, Joelle Rode, Silvia R. B. Uliana
Published 2021-06-01

Erratum to: Ethics review of studies during public health emergencies - the experience of the WHO ethics review committee during the Ebola virus disease epidemic

by Emilie Alirol, Annette C. Kuesel, Maria Magdalena Guraiib, Vânia de la Fuente-Núñez, Abha Saxena, Melba F. Gomes
Published 2017-07-01

The consequence of COVID-19 on the global supply of medical products: Why Indian generics matter for the world? [version 1; peer review: 3 approved, 1 approved with reservations]

by Philippe J Guerin, Sauman Singh-Phulgenda, Nathalie Strub-Wourgaft
Published 2020-04-01

Chagas disease research and development: Is there light at the end of the tunnel?

by Eric Chatelain
Published 2017-01-01

Product Development Partnerships: Delivering Innovation for the Elimination of African Trypanosomiasis?

by Emma Michelle Taylor, James Smith
Published 2020-01-01